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The 2004 Newborn Screening Act has saved a lot of
Filipinos from Congenital Adrenal Hyperplasia (CAH).
The increase in the number of patients living with CAH
challenges us to find the optimal steroid replacement
therapy. In the Philippines, there is no locally published
data on this. The objectives of the paper are to compare
the effect of different hydrocortisone dosing regimen on
the 17 hydroxyprogesterone (17 OHP) levels of patients
with CAH and to report adverse effects.
The pilot study is a single-blinded randomized control
trial comparing the 17 OHP levels of infants with CAH
given higher evening hydrocortisone dose (HED), higher
morning hydrocortisone dose (HMD) and equal hydrocor-
tisone dose (EHD) who consulted in a tertiary hospital
from January 2011 to July 2011. Nine patients completed
the study (3 males and 6 females) with mean age of 16
(+11) months. One patient was randomized to HMD, 5 to
HED and 3 to EHD. A marginally significant difference
(p-value=0.0515) in the 17 OHP levels was observed
between treatment groups. Adverse effects included
increased BMI with concomitant presence of cushingoid
facies in 33% (3/9) of the patients and an increased growth
velocity in one patient in the HED group.
A significant difference was observed between treatment
groups. The decrease in 17OHP was best appreciated in
the EHD group but no definitive conclusion can be made
on the optimal treatment schedule due to the small sam-
ple size. It is recommended that a larger study be done on
newly diagnosed neonates with CAH using 525 patients
(11 for HMD, 257 for HED and 257 for EHD) and ACTH
levels be included in the outcome measures. Also, the
use of oral steroids available in the country such as Predni-
sone or Dexamethasone as an alternative treatment be
investigated.
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